Chonburi project
Sirio Furthers Global Expansion With Thai Multipurpose Manufacturing Investment
SIRIO Pharma (China), the global nutraceutical contract development and manufacturing organization (CDMO), has announced plans to commence work on a new production site in Chonburi, Thailand. On the back of record revenues during 2023 – Sirio announced in May, 2024 a 42.87 percent year-on-year revenue rise to $508 million [€469 million] – the CDMO is continuing ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.


